Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-31 Sale |
2023-06-02 6:05 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $8.6294 | $25,888 | 1,281,170 (Direct) |
View |
| 2023-05-30 Sale |
2023-06-01 5:41 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $8.7939 | $78,134 | 7,540,747 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-17 6:22 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $5.0918 | $45,241 | 7,549,632 (Direct) |
View |
| 2023-05-03 Sale |
2023-05-05 6:44 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
58,073 | $4.7928 | $278,335 | 30,174,484 (Indirect Direct) |
View |
| 2022-01-05 Sale(A) |
2023-04-28 4:32 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
18,500 | $7.3875 | $136,669 | 73,549,979 (Direct) |
View |
| 2023-04-18 Sale |
2023-04-20 5:37 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $5.9347 | $52,730 | 7,558,517 (Direct) |
View |
| 2023-04-05 Sale |
2023-04-07 5:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
53,327 | $6.5953 | $351,710 | 10,584,055 (Indirect Direct) |
View |
| 2023-04-04 Sale |
2023-04-06 5:38 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $6.5269 | $57,992 | 7,567,402 (Direct) |
View |
| 2023-03-21 Sale |
2023-03-23 5:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $7.3994 | $65,744 | 7,576,287 (Direct) |
View |
| 2023-03-08 Sale |
2023-03-10 5:34 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
110,890 | $8.0521 | $892,894 | 10,650,382 (Indirect Direct) |
View |
| 2023-03-07 Sale |
2023-03-09 5:36 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $8.3274 | $73,989 | 7,585,172 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $7.9175 | $166,268 | 10,771,272 (Indirect Direct) |
View |
| 2023-03-02 Purchase |
2023-03-03 4:09 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
66,822 | $7.8171 | $522,354 | 20,048,796 (Indirect) |
View |
| 2023-03-01 Purchase |
2023-03-02 4:05 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
48,867 | $7.9416 | $388,082 | 19,981,974 (Indirect) |
View |
| 2023-02-28 Purchase |
2023-03-01 4:06 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
815 | $7.97 | $6,496 | 19,933,107 (Indirect) |
View |
| 2023-02-27 Purchase |
2023-02-28 4:14 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
52,500 | $7.69 | $403,725 | 19,932,292 (Indirect) |
View |
| 2023-02-23 Sale |
2023-02-27 5:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $7.8175 | $62,540 | 1,287,854 (Direct) |
View |
| 2023-02-24 Purchase |
2023-02-27 4:06 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
109,118 | $7.639 | $833,552 | 19,879,792 (Indirect) |
View |
| 2023-02-23 Purchase |
2023-02-24 4:08 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
51,864 | $7.7856 | $403,792 | 19,770,674 (Indirect) |
View |
| 2023-02-21 Sale |
2023-02-23 5:48 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $7.733 | $68,708 | 7,594,057 (Direct) |
View |
| 2023-02-22 Purchase |
2023-02-23 4:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
50,941 | $7.8329 | $399,016 | 19,718,810 (Indirect) |
View |
| 2023-02-21 Purchase |
2023-02-22 4:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
94,418 | $7.7435 | $731,126 | 19,667,869 (Indirect) |
View |
| 2023-02-17 Purchase |
2023-02-21 4:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
63,382 | $7.7149 | $488,986 | 19,573,451 (Indirect) |
View |
| 2023-02-16 Purchase |
2023-02-17 5:27 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
42,682 | $7.8966 | $337,043 | 19,510,069 (Indirect) |
View |
| 2023-02-15 Sale |
2023-02-17 5:13 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
9,254 | $8.3472 | $77,245 | 1,115,194 (Direct) |
View |
| 2023-02-14 Purchase |
2023-02-15 4:06 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
6,300 | $7.946 | $50,060 | 19,467,387 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-31 Exercise |
2023-06-02 6:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $1.06 | 1,281,170 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-02 6:05 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $0 | 1,281,170 (Direct) |
View |
| 2023-05-15 Tax Withholding |
2023-05-17 6:20 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
2,230 | $5.6 | 185,102 (Direct) |
View |
| 2023-05-15 Tax Withholding |
2023-05-17 6:19 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
5,415 | $5.6 | 422,429 (Direct) |
View |
| 2023-05-15 Tax Withholding |
2023-05-17 6:17 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
4,760 | $5.6 | 790,159 (Direct) |
View |
| 2023-05-15 Tax Withholding |
2023-05-17 6:16 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
11,661 | $5.6 | 941,564 (Direct) |
View |
| 2023-01-05 Gift |
2023-05-05 6:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,000 | $0 | 30,174,484 (Direct) |
View |
| 2023-05-03 Exercise |
2023-05-05 6:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 30,174,484 (Direct) |
View |
| 2023-01-05 Conversion |
2023-05-05 6:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
35,338 | $0 | 30,174,484 (Direct) |
View |
| 2023-05-03 Exercise |
2023-05-05 6:44 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 30,174,484 (Direct) |
View |
| 2023-04-03 Option Award(A) |
2023-04-28 4:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
1,996 | $0 | 57,569 (Direct) |
View |
| 2022-04-25 Gift(A) |
2023-04-28 4:32 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
57,000 | $0 | 73,549,979 (Direct) |
View |
| 2022-04-25 Conversion(A) |
2023-04-28 4:32 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
75,500 | $0 | 73,549,979 (Direct) |
View |
| 2022-02-04 Tax Withholding(A) |
2023-04-28 4:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
678 | $11.4 | 590,380 (Direct) |
View |
| 2022-02-04 Option Award(A) |
2023-04-28 4:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
60,299 | $0 | 590,380 (Direct) |
View |
| 2023-04-05 Gift |
2023-04-07 5:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,584,055 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 5:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,584,055 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 5:30 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,584,055 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 6:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
1,996 | $0 | 22,561 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 6:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
1,542 | $0 | 13,627,162 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 6:02 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
2,721 | $0 | 38,405 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 6:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,724 | $0 | 3,810,457 (Direct) |
View |
| 2023-03-13 Gift |
2023-03-15 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
3,000 | $0 | 10,647,382 (Direct) |
View |
| 2023-03-13 Conversion |
2023-03-15 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
3,000 | $0 | 10,647,382 (Direct) |
View |
| 2023-03-08 Gift |
2023-03-10 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,650,382 (Direct) |
View |
| 2023-03-08 Exercise |
2023-03-10 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
93,750 | $2.48 | 10,650,382 (Direct) |
View |
| 2023-03-08 Conversion |
2023-03-10 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,650,382 (Indirect) |
View |
| 2023-03-08 Exercise |
2023-03-10 5:34 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
93,750 | $0 | 10,650,382 (Direct) |
View |
| 2023-03-02 Conversion |
2023-03-06 6:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,771,272 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 5:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $1.06 | 1,287,854 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 5:46 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $0 | 1,287,854 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:16 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
1,603 | $8.44 | 427,844 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
1,258 | $8.44 | 794,310 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,346 | $8.44 | 940,927 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 5:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
7,486 | $2.22 | 1,115,194 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 5:13 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
7,486 | $0 | 1,115,194 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
746 | $8.44 | 1,115,194 (Direct) |
View |